Claudia Morato Guimaraes

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2− metastatic breast cancer

Gebra Cuyún Carter, Kristin M. Sheffield, Anala Gossai et al. · Current Medical Research and Opinion · 2021 · 39 citations

Medicine, Oncology, Pharmacotherapy +17

Real world incidence and management of adverse events in patients with HR+, HER2− metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting

Gregory L. Price, Lavanya Sudharshan, Paula D. Ryan et al. · Current Medical Research and Opinion · 2022 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical and Genomic Characteristics of Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors

Xi Rao, Yongmei Chen, Julie Beyrer et al. · Clinical Cancer Research · 2023 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17